You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1246 Immune related adverse events to checkpoint inhibitors are associated with altered regulatory T cell phenotypes and resemble CTLA4-deficient patients

Alerts

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
1246 Immune related adverse events to checkpoint inhibitors are associated with altered regulatory T cell phenotypes and resemble CTLA4-deficient patients
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address